Skip to main content

(Approval lapsed) Dutasteride 0.5mg capsules (Camber Pharmaceuticals)

Section 19A approved medicine
(Approval lapsed) Dutasteride 0.5mg capsules (Camber Pharmaceuticals)
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 516
Phone
1800 181 060
Approved until
Status
Expired
Medicines in short supply/unavailable
APO-Dutasteride dutasteride 500 microgram soft capsule blister pack - AUST R: 212047
Indication(s)

Dutasteride is indicated for use as monotherapy for the management of symptomatic benign prostatic hyperplasia (BPH) or as combination therapy with an alpha blocker which is approved for use in BPH and which has been dose titrated in accordance with the relevant recommendations in the product information for that alpha blocker.

Help us improve the Therapeutic Goods Administration site